Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
Biotechnology, Life Science
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Genespire? We’re happy to assist you with our Startup Sourcing service.